The health system’s digital transformation arm, Mayo Clinic Platform, plans to use TripleBlind’s software to analyze patient data without seeing, sharing or storing it and test artificial intelligence models with Mayo’s Validate program while preserving intellectual property rights.
“Mayo Clinic Platform’s vision is to create a healthier world where personalized, predictive and innovative care may be accessible to all,” said Steve Bethke, vice president of Mayo Clinic Platform’s product portfolio, in a Jan. 31 TripleBlind news release. “We’re excited to collaborate with TripleBlind to enable solution developers to Validate their models, driving data-driven and scalable innovation in a secure environment.”
Mayo began investing in TripleBlind and using its application programming interface for digital health research in 2021.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
